NCT06618976View on ClinicalTrials.gov

Antithrombotic Activities of Sotagliflozin vs. Empagliflozin

PHASE4RecruitingINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

February 25, 2025

Primary Completion Date

February 27, 2026

Study Completion Date

February 27, 2026

Conditions
Thrombosis
Interventions
DRUG

Sotagliflozin

Sotagliflozin 400 mg, P.O. once daily for 1 month.

DRUG

Empagliflozin

Empagliflozin 10 mg, P.O. once daily for 1 month.

Trial Locations (1)

10029

RECRUITING

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors
lead

Icahn School of Medicine at Mount Sinai

OTHER